학술논문
Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial
Document Type
Article
Author
Turan, Alparslan; Duncan, Andra; Leung, Steve; Karimi, Nika; Fang, Jonathan; Mao, Guangmei; Hargrave, Jennifer; Gillinov, Marc; Trombetta, Carlos; Ayad, Sabry; Hassan, Manal; Feider, Andrew; Howard-Quijano, Kimberly; Ruetzler, Kurt; Sessler, Daniel I; Bergese, Sergio; De Oliveira, Gildasio; Honar, Hooman; Niazi, Azfar; Elliott, Kavita; Hamadnalla, Hassan; Chodavarapu, Praneeta; Bajracharya, Gausan; Fitzgerald, Paul; Cuko, Evis; Akhtar, Zohaib; Lokhande, Chetan; Khan, Mohammad Zafeer; Khoshknabi, Dilara; Riter, Quinton; Hutcherson, Matthew; Yagar, Seyhan; Glosse, Logan; Saha, Partha; Raza, Syed
Source
The Lancet; July 2020, Vol. 396 Issue: 10245 p177-185, 9p
Subject
Language
ISSN
01406736; 1474547X
Abstract
Atrial fibrillation and delirium are common consequences of cardiac surgery. Dexmedetomidine has unique properties as sedative agent and might reduce the risk of each complication. This study coprimarily aimed to establish whether dexmedetomidine reduces the incidence of new-onset atrial fibrillation and the incidence of delirium.